G

Galmed Pharmaceuticals Ltd
D

GLMD

2.09000
USD
0.25
(13.59%)
مغلق
حجم التداول
0
الربح لكل سهم
-1
العائد الربحي
-
P/E
-0
حجم السوق
4,719,291
أصول ذات صلة
A
ALKS
0.145
(0.50%)
29.385 USD
A
ARDX
0.13000
(2.98%)
4.49000 USD
C
CRIS
0.15000
(8.72%)
1.87000 USD
I
IMAB
0.11000
(5.24%)
2.21000 USD
L
LXRX
0.04240
(4.87%)
0.91340 USD
R
RGNX
0.31000
(3.68%)
8.74000 USD
S
SRRK
-1.270
(-3.58%)
34.230 USD
V
VYGR
0.12500
(4.11%)
3.17000 USD
المزيد
الأخبار المقالات

العنوان: Galmed Pharmaceuticals Ltd

القطاع: Healthcare
الصناعة: Biotechnology
Galmed Pharmaceuticals Ltd is a biopharmaceutical company. It focuses on the development of Aramchol. exclusively on developing Aramchol for the treatment of liver disease and were previously developing Aramchol for primary sclerosing cholangitis, PSC, and exploring the feasibility of developing Aramchol for other fibro-inflammatory indications outside of NASH and fibrosis. The company is currently seeking to advance the development of Aramchol for oncological indications outside of NASH and fibrosis.